NCT04289155No Longer Available不适用
Individual Patient Compassionate Use of GX-I7
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
- 试验地点
- 1
研究概览
简要总结
Compassionate use of GX-I7 for patients with serious life-threatening illness that have exhausted all available therapies, with no other therapy options.
详细描述
This program is being offered on a patient by patient basis and will require company, Institutional Review Board/Independent Ethics Committee and Single Patient IND approval.
研究设计
- 研究类型
- Expanded Access
入排标准
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
GX-I7 With Cyclophosphamide in Patients With Metastatic or Recurrent Solid TumorsSolid TumorNCT03733587Genexine, Inc.24
进行中（未招募）
2 期
GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) PatientsRecurrent GlioblastomaNCT05191784Genexine, Inc.20
Available
不适用
Individual Patient Compassionate Use of NirogacestatDesmoid TumorNOTCH Gene Mutation Positive TumorsNCT05041036SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
No Longer Available
不适用
Individual Patient Expanded Access-Glembatumumab VedotinMetastatic gpNMB Expressing Triple Negative Breast CancerNCT03067935Celldex Therapeutics
Available
不适用
GSK1265744 (Cabotegravir, CAB) for Named Patient/Compassionate Use in HIVInfection, Human Immunodeficiency VirusNCT03462810ViiV Healthcare